NEW!

Saturday, April 16
1:00 p.m.–3:00 p.m. Scientific Platform Sessions
S4: Health Disparities and Sex
Differences in Stroke
1:00 p.m. S4.001
Association of Black Race with
Recurrent Stroke Risk —Jong-Ho Park,
Bruce Ovbiagele
1:15 p.m. S4.002
COLADAS: Caribbean Origin Latin
American’s Disparities in Acute
Stroke —Ina Teron Molina, Abiezer
Rodríguez Centeno, Fernando Santiago,
Mariel López Valentín
1:30 p.m. S4.003
African Americans Are Less Likely to
Be Adherent to Statins After Ischemic
Stroke: An Analysis of Medicare
Beneficiaries Following Hospital
Discharge —Karen Albright, Justin
Blackburn, Hong Zhao, T. Beasley, Nita
Limdi, Virginia Howard, Paul Muntner
1:45 p.m. S4.004
Subarachnoid Hemorrhage with and
Without Concomitant Sickle Cell
Disease, a Comparison Using the
Nationwide Inpatient Sample —Fatmah
Al Zahmi, James Conners, Shawna Cutting,
Laurel Cherian, Sarah Song, Vivien Lee,
Rajeev Garg, Bichun Ouyang
2:00 p.m. S4.005
Age Disparities in Acute Stroke
Treatment: An Analysis of Six Years
of US Hospital Discharges —Michael
Lyerly, Karen Albright, Toby Gropen, Katrina
Booth, Mark Harrigan
2:15 p.m. S4.006
Primary Stroke Prevention in Women —
Puja Patel, Brian Tark, Ketevan Berekashvili,
Leah Steinberg, Clotilde Balucani, Jeremy
Weedon, Alla Akivis, Richard Sadovsky,
Grigol Adeishvili, Nagaraj Gabbur, Zachary
Adler, Lavanya Chekuru, Ovadia Abulafia,
Steven Weiss, Steven Levine
2:30 p.m. S4.007
Risk of Pregnancy-Associated Stroke
Across Age Groups: Population-Based
Data from New York State —Eliza
Miller, Hajere Gatollari, Gloria Too, Amelia
Boehme, Anna Colello, Lisa Leffert,
Mitchell Elkind, Joshua Willey
2:45 p.m. S4.008
Previous Use of Unopposed Estrogen
Hormone Replacement Therapy
Continues to Cause Increased Risk
for Future Ischemic Strokes —Haseeb
Rahman, Abraham Thomas, Ahmed Malik,
Omar Saeed, Adnan Qureshi
S5: Movement Disorders:
Parkinson's Disease and
Atypical Parkinsonian
Syndromes: Biomarkers
1:00 p.m. S5.001
Tau Imaging in Atypical Parkinsonism:
Preliminary Evidence with [11C]PBB3
PET in PSP Subjects —Alexandra Perez
Soriano, Julieta Arena, Jenna Smith-
Forrester, Nasim Vafai, Elham Shahinfard,
Qing Miao, Paul Schaffer, Hitoshi Shinotoh,
Makoto Higuchi, Vesna Sossi, A Stoessl
1:15 p.m. S5.002
Modeling Trajectories of Brain Damage
in Progressive Supranuclear Palsy: A
Longitudinal Multimodal MRI Study —
Francesca Caso, Federica Agosta, Milica
Lukić-Ječmenica, Igor Petrović, Paola
Valsasina, Pilar Maria Ferraro, Alessandro
Meani, Massimiliano Copetti, Vladimir
Kostic, Massimo Filippi
1:30 p.m. S5.003
Retinal and Visual Cortex Damage and
Higher Order Visual Dysfunction in
Carriers of E46K Mutation of Alpha-
Synuclein Gene —Inigo Gabilondo,
Marta Galdos, Alvaro Arjonilla, Amaia
Gonzalez, Begoña Arana, Marian Acera,
Alberto Cabrera, Carmen Alonso, Rocio del
Pino, Olaia Lucas, Natalia Ojeda, Naroa
Ibarretxe-Bilbao, Juan Carlos Gomez
Esteban
1:45 p.m. S5.004
Elevated Systolic Blood Pressure
Predicts Motor Outcomes in
Parkinson’s Disease--A Retrospective
Analysis of the CALM-PD Trial —
Christina Lineback, Roger Albin, Nicolaas
Bohnen, Vikas Kotagal, The Parkinson
Study Group CALM-PD Investigators
2:00 p.m. S5.005
Trajectories of Prediagnostic Motor and
Non-Motor Functioning in Parkinson
Disease —Sirwan Darweesh, Vincentius
Verlinden, Bruno Stricker, Albert Hofman,
Peter Koudstaal, Mohammad Ikram
2:15 p.m. S5.006
In Synucleinopathies, Elevated
Ratios of Cysteinyl-Dopamine:3,4-
Dihydroxyphenylacetic Acid (DOPAC)
in Cerebrospinal Fluid Are Associated
Specifically with Parkinsonism —David
Goldstein, Courtney Holmes, Irwin Kopin,
Yehonatan Sharabi
2:30 p.m. S5.007
Olfactory Function Predicts Cognitive
Deficits and Decline in Early Parkinson's
Disease —Michelle Fullard, Baochan Tran,
Sharon Xie, Christi Scordia, Carly Linder,
Rachael Purri, Daniel Weintraub, John
Duda, Lama Chahine, James Morley
2:45 p.m. S5.008
Gastric and Colonic Mucosal Alpha-
Synuclein Immunostaining As a
Biomarker for Parkinson’s Disease —
Sun J. Chung, Juyeon Kim, Hyo Jeong
Lee, Ho-Sung Ryu, Kee Wook Jung, Mi
Jung Kim, Mi-Jung Kim, Seung-Mo Hong,
Seung-Jae Myung
Meeting Schedule
1:00 p.m.–3:00 p.m.
S4 Health Disparities and Sex Differences
in Stroke
S5
C29
C30
C31
C32
C33
C34
C35
C36
C37
C38
C39
Real World
of Neurology
Movement Disorders:
Parkinson’s Disease and Atypical
Parkinsonian Syndromes: Biomarkers
Ask the Expert: Solo / Small Practitioners
Director: Brad C. Klein, MD, MBA, FAAN, Willow Grove, PA
Assessment of Rapidly Progressive Dementias and
Related Neurologic Conditions I
Director: Steven Vernino, MD, PhD, FAAN, Dallas, TX
Chronic Migraine Education Program I
Director: Richard B. Lipton, MD, FAAN, Bronx, NY
Hyperkinetic Movement Disorders: Videodiagnosis
and Treatment
Director: Oksana Suchowersky, MD, FAAN, Edmonton, AB
Multiple Sclerosis Overview: Clinical Advances I
Director: Myla Goldman, MD, Charlottesville, VA
Peripheral Neuropathy II
Director: Michael E. Shy, MD, Iowa City, IA
Case Studies: Neurologic Consultations in Cancer
Patients I
Director: Amy A. Pruitt, MD, Philadelphia, PA
Differential Diagnosis of Neurologic Infections
Director: Allen J. Aksamit, Jr., MD, FAAN, Rochester, MN
Neuroimaging for the General Neurologist: Spine
and Peripheral Nerve I
Director: Joshua Klein, MD, PhD, Boston, MA
Clinical EEG II
Director: Susan T. Herman, MD, FAAN, Boston, MA
$ Sports Concussion Skills Workshop I
(registration required)
Director: Vernon B. Williams, MD, Los Angeles, CA
Autoimmune Neurology I
Director: Maarten Jan Titulaer, MD, PhD,
Rotterdam, The Netherlands
1:00 p.m.–5:00 p.m.
C40 Resident Basic Science III: Neuropharmacology
Director: James W. M. Owens, Jr., MD, PhD, Seattle, WA
Sat · April 16
Fast and easy registration · AAN.com/view/AM16 37